Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Nakamura

Showing results (1-10 of 1,044) with videos related to

Pageof 105
Sort By:
Cancer Science|January 27, 2011
Retraction: Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell linesYusuke Nakamura
Cancer Science|January 27, 2011
Retraction: Epstein-Barr virus-encoded latent membrane protein 1 activates β-catenin signaling in B lymphocytesYusuke Nakamura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 27, 2003
[Genomic medicine]Yusuke Nakamura
Cancer Science|September 8, 2011
Retracted: Modulation of p53 /Akt / phosphatase and tensin homolog expression by esculetin potentiates the anticancer activity of cisplatin and prevents its nephrotoxicityYusuke Nakamura
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
The current and future applications of immunopharmacogenomicsYusuke Nakamura
JMA Journal|February 28, 2022
Japanese Cross-ministerial Strategic Innovation Promotion Program "Innovative AI Hospital System"; How Will the 4th Industrial Revolution Affect Our Health and Medical Care System?Yusuke Nakamura
Cancer Science|January 27, 2011
Retraction: Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene)Yusuke Nakamura
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Cancer vaccinesYusuke Nakamura
Journal of Human Genetics|January 23, 2009
DNA variations in human and medical genetics: 25 years of my experienceYusuke Nakamura
Cancer Science|February 23, 2011
Retraction. Cloning and expression of soluble recombinant human esophageal cancer-related gene 4 protein and its inhibitory effect on tumor growth in vitro and in vivo in esophageal carcinomaYusuke Nakamura
Pageof 105

Showing results (1-10 of 1,044) with videos related to

Sort By:
Pageof 105
Cancer Science|January 27, 2011
Retraction: Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell linesYusuke Nakamura
Cancer Science|January 27, 2011
Retraction: Epstein-Barr virus-encoded latent membrane protein 1 activates β-catenin signaling in B lymphocytesYusuke Nakamura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 27, 2003
[Genomic medicine]Yusuke Nakamura
Cancer Science|September 8, 2011
Retracted: Modulation of p53 /Akt / phosphatase and tensin homolog expression by esculetin potentiates the anticancer activity of cisplatin and prevents its nephrotoxicityYusuke Nakamura
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
The current and future applications of immunopharmacogenomicsYusuke Nakamura
JMA Journal|February 28, 2022
Japanese Cross-ministerial Strategic Innovation Promotion Program "Innovative AI Hospital System"; How Will the 4th Industrial Revolution Affect Our Health and Medical Care System?Yusuke Nakamura
Cancer Science|January 27, 2011
Retraction: Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene)Yusuke Nakamura
Clinical Advances in Hematology & Oncology : H&O|January 19, 2012
Cancer vaccinesYusuke Nakamura
Journal of Human Genetics|January 23, 2009
DNA variations in human and medical genetics: 25 years of my experienceYusuke Nakamura
Cancer Science|February 23, 2011
Retraction. Cloning and expression of soluble recombinant human esophageal cancer-related gene 4 protein and its inhibitory effect on tumor growth in vitro and in vivo in esophageal carcinomaYusuke Nakamura
Pageof 105